SCHEDULE 13G: Perceptive Entities Disclose 6.7% Stake in Anteris Technologies Global Corp.
Beneficial Ownership Report
Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have jointly reported a 6.7% beneficial ownership stake in Anteris Technologies Global Corp., totaling 2,440,000 shares.
Summary
- Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. (collectively, the "Reporting Persons") have filed a Schedule 13G disclosing their beneficial ownership in Anteris Technologies Global Corp. (the "Issuer").
- The Reporting Persons collectively beneficially own 2,440,000 shares of Anteris Technologies Global Corp.'s Common Stock.
- This ownership represents 6.7% of the Issuer's outstanding Common Stock.
- The calculation of the percentage is based on 35,939,816 outstanding shares of Common Stock, as reported in the Issuer's prospectus filed on December 13, 2024, and includes the assumption of exercise of 300,000 warrants held by the Reporting Persons.
- Perceptive Life Sciences Master Fund, Ltd. directly holds 2,140,000 shares of Common Stock and 300,000 immediately exercisable warrants.
- Perceptive Advisors LLC serves as the investment manager to the Master Fund, and Joseph Edelman is the managing member of Perceptive Advisors LLC, leading to shared beneficial ownership of these shares.
Sentiment
Score: 5
Explanation: Neutral, as this is a factual disclosure of beneficial ownership and does not contain positive or negative operational or financial news.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- This filing indicates a significant institutional investor, Perceptive Life Sciences Master Fund, Ltd., holds a substantial stake, which could be viewed positively by other shareholders as a vote of confidence.
- The disclosure provides transparency to the market regarding the ownership structure of Anteris Technologies Global Corp.
Key Dates
| Date | Description |
|---|---|
| 2024-12-13 | Date of Issuer's prospectus filing reporting 35,939,816 outstanding shares. |
| 2024-12-31 | Date of event which required the filing of this statement (beneficial ownership threshold reached/maintained). |
| 2025-02-14 | Date of filing of this Schedule 13G statement. |
Keywords
Anteris Technologies Global Corp, Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Schedule 13G, beneficial ownership, common stock, institutional ownership, SEC filing, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.